ReviewFrontiers in immunology2024

Transarterial chemoembolization combined with atezolizumab plus bevacizumab conversion therapy for intermediate-stage hepatocellular carcinoma: a case report and literature review.

Haidong Ai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.